Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q2 2014 · 10-Q
Revenue$222.00$222.00+73.4% vs Q2 2013 Net Income-$123.88K-$123.88KN/M vs Q2 2013 EPS, diluted—
Operating Income-$98,253N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived-$99,197— Margins · derivedGross margin-1026.1%+9487.2 pt vs Q2 2013
Operating margin-44258.1%+54759.1 pt vs Q2 2013
Net margin-55802.7%+42140.3 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 14, 2014 · 45 d after period end